Investors finance the different links that together form the global production chains for medical devices, pharmaceutical and other care-related products. Governments and companies must ensure that these products are available all over the world.
Senior Advisor Responsible Investment
Manufacturers of pharmaceuticals take inappropriate risks if they charge excessive prices for their medications. As a shareholder, we do not want to see maximisation of profit at the expense of health care.